Taiwan FDA registration 9b330dcca0795217d364ae60b17d35ad
Remai dysentery amoeba test panel
TW: 銳邁 痢疾阿米巴檢驗試劑組
Taiwan·Risk Class 1·REMEL EUROPE LIMITED·Registered Apr 28, 2006 – Apr 28, 2011CancelledRegistration details
- Analysis ID
- 9b330dcca0795217d364ae60b17d35ad
- Customs Code
- DHA04400426500
Company information
- Manufacturer
- REMEL EUROPE LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- Qixin Biotechnology Co., Ltd
Product details
- Intended Use
- 用於定性偵測人類糞便之萃取液中之痢疾阿米巴專一性抗原(Entamoeba histolytica specific antigen, EHSA).
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3220 痢疾阿米巴血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Apr 28, 2006
- Expiry Date
- Apr 28, 2011
- Cancellation Date
- Nov 08, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Remai dysentery amoeba test panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 9b330dcca0795217d364ae60b17d35ad and manufactured by REMEL EUROPE LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices